Compare APTV & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APTV | DVA |
|---|---|---|
| Founded | 2011 | 1994 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Misc Health and Biotechnology Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.5B | 13.5B |
| IPO Year | 2011 | 2003 |
| Metric | APTV | DVA |
|---|---|---|
| Price | $63.54 | $208.85 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 17 | 4 |
| Target Price | $88.80 | ★ $156.75 |
| AVG Volume (30 Days) | ★ 4.0M | 658.6K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.88 | ★ 2.87 |
| Revenue | ★ $20,398,000,000.00 | $13,643,069,000.00 |
| Revenue This Year | $7.40 | $3.85 |
| Revenue Next Year | $4.87 | $3.07 |
| P/E Ratio | ★ $72.36 | $72.44 |
| Revenue Growth | 3.47 | ★ 6.46 |
| 52 Week Low | $51.68 | $101.00 |
| 52 Week High | $88.93 | $213.44 |
| Indicator | APTV | DVA |
|---|---|---|
| Relative Strength Index (RSI) | 48.00 | 68.26 |
| Support Level | $57.16 | $189.09 |
| Resistance Level | $87.98 | N/A |
| Average True Range (ATR) | 3.48 | 5.89 |
| MACD | -0.82 | 0.21 |
| Stochastic Oscillator | 6.50 | 79.11 |
Aptiv PLC is an industrial technology company focused on enabling a more automated, electrified and digitalized future. The company's technologies reach from sensor to cloud, including the hardware and software necessary to support automotive and other industries on a global basis. Its Advanced Safety and User Experience segment provides advanced software and services, intelligent sensors and high-performance compute platforms; its Engineered Components Group segment provides connection systems, high-performance interconnects, and cable management and protection solutions; and its Electrical Distribution Systems segment provides low voltage and high voltage power, signal and data distribution.
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.